Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.

Calaway AC, Tachibana I, Masterson TA, Foster RS, Einhorn LH, Cary C.

Urology. 2019 May;127:74-79. doi: 10.1016/j.urology.2019.02.014. Epub 2019 Feb 23.

PMID:
30807775
2.

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI.

Int J Clin Oncol. 2018 Dec;23(6):1121-1126. doi: 10.1007/s10147-018-1316-1. Epub 2018 Jul 10.

PMID:
29992389
3.

Robotic Sacral Colpopexy.

Powell CR, Tachibana I, Eckrich B, Rothenberg J, Hathaway J.

J Endourol. 2018 May;32(S1):S111-S116. doi: 10.1089/end.2018.0054.

PMID:
29774820
4.

Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.

Jin Y, Takeda Y, Kondo Y, Tripathi LP, Kang S, Takeshita H, Kuhara H, Maeda Y, Higashiguchi M, Miyake K, Morimura O, Koba T, Hayama Y, Koyama S, Nakanishi K, Iwasaki T, Tetsumoto S, Tsujino K, Kuroyama M, Iwahori K, Hirata H, Takimoto T, Suzuki M, Nagatomo I, Sugimoto K, Fujii Y, Kida H, Mizuguchi K, Ito M, Kijima T, Rakugi H, Mekada E, Tachibana I, Kumanogoh A.

Sci Rep. 2018 Mar 23;8(1):5145. doi: 10.1038/s41598-018-23338-x.

5.

Tumor Hypoxia Detected by 18F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).

Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M.

Anticancer Res. 2018 Mar;38(3):1775-1781.

PMID:
29491116
6.

Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy.

Hutchinson R, Singla N, Krabbe LM, Woldu S, Chen G, Rew C, Tachibana I, Lotan Y, Cadeddu JA, Margulis V.

Urol Oncol. 2017 Nov;35(11):660.e17-660.e25. doi: 10.1016/j.urolonc.2017.06.057. Epub 2017 Jul 15.

PMID:
28720410
7.

Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease-Like Pathophysiology.

Sakai H, Horiguchi M, Akita T, Ozawa C, Hirokawa M, Oiso Y, Kumagai H, Takeda Y, Tachibana I, Maeda N, Yamashita C.

J Pharmacol Exp Ther. 2017 Jun;361(3):501-505. doi: 10.1124/jpet.117.240515. Epub 2017 Apr 21.

PMID:
28432078
8.

Standing cough test for evaluation of post-prostatectomy incontinence: a pilot study.

Morey AF, Singla N, Carmel M, Klein A, Tausch TJ, Siegel J, Tachibana I, Scott J.

Can J Urol. 2017 Feb;24(1):8664-8669.

9.

Improved quality of life in asthma patients under long-term therapy: Assessed by AHQ-Japan.

Tohda Y, Iwanaga T, Sano H, Kume H, Hirata K, Ohkura N, Tachibana I, Nishimura Y, Matsumoto H, Minakata Y, Yoshikawa M, Fujimura M; Kansai & Hokuriku Academy for Asthma Treatment.

Int J Clin Pract. 2017 Jan;71(1). doi: 10.1111/ijcp.12898. Epub 2016 Dec 9.

PMID:
27933734
10.

Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.

Matsuura T, Nishimura Y, Nakamatsu K, Kanamori S, Ishikawa K, Tachibana I, Hosono M, Shibata T.

Int J Clin Oncol. 2017 Feb;22(1):52-58. doi: 10.1007/s10147-016-1034-5. Epub 2016 Sep 7.

PMID:
27604973
11.

Rapid excision of massive localized lymphedema of the male genitalia with vessel sealing device.

Siegel JA, Zhao L, Tachibana I, Carlson S, Tausch TJ, Klein AK, Vanni A, Rozanski T, Morey AF.

Can J Urol. 2016 Jun;23(3):8291-5.

PMID:
27347623
12.

Classification System for Individualized Treatment of Adult Buried Penis Syndrome.

Tausch TJ, Tachibana I, Siegel JA, Hoxworth R, Scott JM, Morey AF.

Plast Reconstr Surg. 2016 Sep;138(3):703-11. doi: 10.1097/PRS.0000000000002519.

PMID:
27152580
13.

Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells.

Sun J, Wang J, Pefanis E, Chao J, Rothschild G, Tachibana I, Chen JK, Ivanov II, Rabadan R, Takeda Y, Basu U.

Cell Rep. 2015 Nov 10;13(6):1110-1117. doi: 10.1016/j.celrep.2015.09.070. Epub 2015 Oct 29.

14.

Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration.

Wei CX, Sun A, Yu Y, Liu Q, Tan YQ, Tachibana I, Zeng H, Wei JY.

Adv Exp Med Biol. 2016;854:103-9. doi: 10.1007/978-3-319-17121-0_15.

PMID:
26427400
15.

Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.

Takeda Y, Suzuki M, Jin Y, Tachibana I.

Am J Respir Cell Mol Biol. 2015 Dec;53(6):751-60. doi: 10.1165/rcmb.2015-0122TR. Review.

PMID:
26378766
16.

Treatment of Hypertrophic Osteoarthropathy With Underlying Pulmonary Adenocarcinoma Using Zoledronic Acid.

Tachibana I, Gehi D, Rubin CD.

J Clin Rheumatol. 2015 Sep;21(6):333-4. doi: 10.1097/RHU.0000000000000289. No abstract available.

PMID:
26267713
17.

Septic pulmonary and systemic embolism in tricuspid endocarditis.

Nii T, Yoshikawa H, Okabe T, Tachibana I.

BMJ Case Rep. 2014 Nov 24;2014. pii: bcr2014206569. doi: 10.1136/bcr-2014-206569.

18.

Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa.

Fujii A, Seki M, Higashiguchi M, Tachibana I, Kumanogoh A, Tomono K.

Respir Med Case Rep. 2014 Mar 26;12:30-3. doi: 10.1016/j.rmcr.2014.03.002. eCollection 2014.

19.

Phase II trial of pemetrexed continuation--maintenance after carboplatin-based induction in untreated non-squamous non-small cell lung cancer.

Minami S, Kijima T, Komuta K, Kumagai T, Imamura F, Yokota S, Takeuchi Y, Nakatani T, Tachibana I, Kawase I.

Anticancer Res. 2013 Dec;33(12):5535-42.

PMID:
24324094
20.

Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.

Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, Kuhara H, Tetsumoto S, Tsujino K, Minami T, Iwasaki T, Nakanishi K, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Ito M, Saya H, Kumanogoh A.

PLoS One. 2013 Sep 9;8(9):e73706. doi: 10.1371/journal.pone.0073706. eCollection 2013.

21.

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.

Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, Takahashi R, Miyake K, Higashiguchi M, Morimura O, Ihara S, Tsujino K, Hirata H, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A.

Sci Rep. 2013;3:2669. doi: 10.1038/srep02669.

22.

A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment.

Nishino K, Imamura F, Morita S, Mori M, Komuta K, Kijima T, Namba Y, Kumagai T, Yamamoto S, Tachibana I, Nakazawa Y, Uchida J, Minami S, Takahashi R, Yano Y, Okuyama T, Kumanogoh A.

Lung Cancer. 2013 Nov;82(2):299-304. doi: 10.1016/j.lungcan.2013.08.009. Epub 2013 Aug 21.

PMID:
24018023
23.

Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status.

Minami S, Kijima T, Hamaguchi M, Nakatani T, Koba T, Takahashi R, Takeuchi Y, Kida H, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I.

Lung Cancer. 2013 Nov;82(2):271-5. doi: 10.1016/j.lungcan.2013.07.022. Epub 2013 Aug 6.

PMID:
23993733
24.

Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.

Shimada K, Serada S, Fujimoto M, Nomura S, Nakatsuka R, Harada E, Iwahori K, Tachibana I, Takahashi T, Kumanogoh A, Kishimoto T, Naka T.

Cancer Sci. 2013 Nov;104(11):1483-91. doi: 10.1111/cas.12266. Epub 2013 Sep 19.

25.

Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9.

He P, Kuhara H, Tachibana I, Jin Y, Takeda Y, Tetsumoto S, Minami T, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Naka T, Morii E, Kawase I, Kumanogoh A.

FEBS Open Bio. 2013 May 10;3:225-30. doi: 10.1016/j.fob.2013.04.005. Print 2013.

26.

Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin.

Nishijima Y, Hirata H, Himeno A, Kida H, Matsumoto M, Takahashi R, Otani Y, Inoue K, Nagatomo I, Takeda Y, Kijima T, Tachibana I, Fujimura Y, Kumanogoh A.

Intern Med. 2013;52(10):1111-4. Epub 2013 May 15.

27.

Validation of noninvasive morphological and diffusion imaging in mouse emphysema by micro-computed tomography and hyperpolarized (129)Xe magnetic resonance imaging.

Tetsumoto S, Takeda Y, Imai H, Kimura A, Jin Y, Nakanishi K, Maeda Y, Kuhara H, Tsujino K, Iwasaki T, Shigeta H, Kondo Y, Ito M, Minami T, Hirata H, Takahashi R, Kohmo S, Nagatomo I, Inoue K, Kida H, Kijima T, Tachibana I, Maeda N, Funahashi T, Shimomura I, Fujiwara H, Kumanogoh A.

Am J Respir Cell Mol Biol. 2013 Oct;49(4):592-600. doi: 10.1165/rcmb.2012-0350OC.

PMID:
23668642
28.

Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.

Takimoto T, Kijima T, Otani Y, Nonen S, Namba Y, Mori M, Yokota S, Minami S, Komuta K, Uchida J, Imamura F, Furukawa M, Tsuruta N, Fujio Y, Azuma J, Tachibana I, Kumanogoh A.

Clin Lung Cancer. 2013 Sep;14(5):502-7. doi: 10.1016/j.cllc.2013.03.003. Epub 2013 May 9.

PMID:
23664723
29.

Favorable responses to tocilizumab in two patients with cancer-related cachexia.

Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, Otani Y, Inoue K, Kuhara H, Shimada K, Nagatomo I, Takeda Y, Goya S, Yoshizaki K, Kawase I, Tachibana I, Kishimoto T, Kumanogoh A.

J Pain Symptom Manage. 2013 Aug;46(2):e9-e13. doi: 10.1016/j.jpainsymman.2013.01.009. Epub 2013 Apr 17. No abstract available.

PMID:
23602326
30.

A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.

Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M.

J Radiat Res. 2013 Nov 1;54(6):1078-84. doi: 10.1093/jrr/rrt033. Epub 2013 Apr 14.

31.

Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.

Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, Tozzi F, Sceusi E, Zhou Y, Tachibana I, Maru DM, Hawke DH, Rak J, Mani SA, Zweidler-McKay P, Ellis LM.

Cancer Cell. 2013 Feb 11;23(2):171-85. doi: 10.1016/j.ccr.2012.12.021. Epub 2013 Jan 31.

32.

Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement in congenital pulmonary airway malformation.

Tetsumoto S, Kijima T, Morii E, Goya S, Minami T, Hirata H, Takahashi R, Kohmo S, Inoue K, Nagatomo I, Takeda Y, Kida H, Tachibana I, Kumanogoh A.

Clin Lung Cancer. 2013 Jul;14(4):457-60. doi: 10.1016/j.cllc.2012.12.005. Epub 2013 Jan 26. No abstract available.

PMID:
23357247
33.

[PMRT(post-mastectomy radiation therapy)].

Kanamori S, Tachibana I, Ishikawa K, Nishikawa T, Nishimura Y.

Nihon Rinsho. 2012 Sep;70 Suppl 7:543-7. Japanese. No abstract available.

PMID:
23350459
34.

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer.

Minami S, Kijima T, Shiroyama T, Okafuji K, Hirashima T, Uchida J, Imamura F, Osaki T, Nakatani T, Ogata Y, Yamamoto S, Namba Y, Otsuka T, Tachibana I, Komuta K, Kawase I.

BMC Res Notes. 2013 Jan 3;6:3. doi: 10.1186/1756-0500-6-3.

35.

Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.

Iwasaki T, Takeda Y, Maruyama K, Yokosaki Y, Tsujino K, Tetsumoto S, Kuhara H, Nakanishi K, Otani Y, Jin Y, Kohmo S, Hirata H, Takahashi R, Suzuki M, Inoue K, Nagatomo I, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I, Kumanogoh A.

J Biol Chem. 2013 Jan 25;288(4):2118-31. doi: 10.1074/jbc.M112.424291. Epub 2012 Dec 5.

36.

Adiponectin: a novel link between adipocytes and COPD.

Takeda Y, Nakanishi K, Tachibana I, Kumanogoh A.

Vitam Horm. 2012;90:419-35. doi: 10.1016/B978-0-12-398313-8.00016-6. Review.

PMID:
23017725
37.

Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.

Otani Y, Kijima T, Kohmo S, Oishi S, Minami T, Nagatomo I, Takahashi R, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Fujii N, Kumanogoh A.

FEBS Lett. 2012 Oct 19;586(20):3639-44. doi: 10.1016/j.febslet.2012.08.011. Epub 2012 Aug 28.

38.

Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer.

Shiroyama T, Kijima T, Komuta K, Yamamoto S, Minami S, Ogata Y, Okafuji K, Imamura F, Hirashima T, Tachibana I, Kawase I, Kumanogoh A.

Cancer Chemother Pharmacol. 2012 Dec;70(6):783-9. doi: 10.1007/s00280-012-1958-z. Epub 2012 Sep 9.

PMID:
22960985
39.

Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study.

Minami S, Kijima T, Takahashi R, Kida H, Nakatani T, Hamaguchi M, Takeuchi Y, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I.

BMC Cancer. 2012 Jul 18;12:296. doi: 10.1186/1471-2407-12-296.

40.

Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.

Ihara S, Kida H, Arase H, Tripathi LP, Chen YA, Kimura T, Yoshida M, Kashiwa Y, Hirata H, Fukamizu R, Inoue R, Hasegawa K, Goya S, Takahashi R, Minami T, Tsujino K, Suzuki M, Kohmo S, Inoue K, Nagatomo I, Takeda Y, Kijima T, Mizuguchi K, Tachibana I, Kumanogoh A.

Cancer Res. 2012 Jun 15;72(12):2990-9. doi: 10.1158/0008-5472.CAN-11-4062. Epub 2012 Jun 1.

41.

Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity.

Tsujino K, Takeda Y, Arai T, Shintani Y, Inagaki R, Saiga H, Iwasaki T, Tetsumoto S, Jin Y, Ihara S, Minami T, Suzuki M, Nagatomo I, Inoue K, Kida H, Kijima T, Ito M, Kitaichi M, Inoue Y, Tachibana I, Takeda K, Okumura M, Hemler ME, Kumanogoh A.

Am J Respir Crit Care Med. 2012 Jul 15;186(2):170-80. doi: 10.1164/rccm.201201-0117OC. Epub 2012 May 16.

42.

Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology.

Turner AM, McGowan L, Millen A, Rajesh P, Webster C, Langman G, Rock G, Tachibana I, Tomlinson MG, Berditchevski F, Naidu B.

Eur Respir J. 2013 Feb;41(2):410-6. doi: 10.1183/09031936.00002912. Epub 2012 May 3.

43.

4-Hydroxy-2-nonenal induces chronic obstructive pulmonary disease-like histopathologic changes in mice.

Takimoto T, Yoshida M, Hirata H, Kashiwa Y, Takeda Y, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I.

Biochem Biophys Res Commun. 2012 Mar 30;420(1):84-90. doi: 10.1016/j.bbrc.2012.02.119. Epub 2012 Mar 3.

PMID:
22405766
44.

HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer.

Minami T, Kijima T, Otani Y, Kohmo S, Takahashi R, Nagatomo I, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A.

Mol Cancer Ther. 2012 Apr;11(4):830-41. doi: 10.1158/1535-7163.MCT-11-0884. Epub 2012 Mar 2.

45.

CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy.

Kohmo S, Kijima T, Mori M, Minami T, Namba Y, Yano Y, Yoneda T, Takeda Y, Kitada S, Yamaguchi T, Tachibana I, Yokota S.

Tuberculosis (Edinb). 2012 May;92(3):248-52. doi: 10.1016/j.tube.2012.01.001. Epub 2012 Jan 30.

PMID:
22297026
46.

Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung.

Takahashi R, Hirata H, Tachibana I, Shimosegawa E, Inoue A, Nagatomo I, Takeda Y, Kida H, Goya S, Kijima T, Yoshida M, Kumagai T, Kumanogoh A, Okumura M, Hatazawa J, Kawase I.

Clin Cancer Res. 2012 Jan 1;18(1):220-8. doi: 10.1158/1078-0432.CCR-11-0868. Epub 2011 Oct 21.

47.

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.

Kijima T, Takeuchi K, Tetsumoto S, Shimada K, Takahashi R, Hirata H, Nagatomo I, Hoshino S, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I.

Cancer Sci. 2011 Aug;102(8):1602-4. doi: 10.1111/j.1349-7006.2011.01970.x.

48.

Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractions.

Nakamatsu K, Nishimura Y, Kanamori S, Koike R, Tachibana I, Nishikawa T, Shibata T.

Strahlenther Onkol. 2011 Jul;187(7):401-5. doi: 10.1007/s00066-011-2212-z. Epub 2011 Jun 27.

PMID:
21713395
49.

Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib.

Tetsumoto S, Osa A, Kijima T, Minami T, Hirata H, Takahashi R, Kuhara H, Nagatomo I, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I.

Int J Clin Oncol. 2012 Apr;17(2):155-9. doi: 10.1007/s10147-011-0256-9. Epub 2011 May 19.

PMID:
21594553
50.

Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism.

Kijima T, Shimizu T, Nonen S, Furukawa M, Otani Y, Minami T, Takahashi R, Hirata H, Nagatomo I, Takeda Y, Kida H, Goya S, Fujio Y, Azuma J, Tachibana I, Kawase I.

J Clin Oncol. 2011 Jul 1;29(19):e588-90. doi: 10.1200/JCO.2010.34.3368. Epub 2011 Apr 18. No abstract available.

PMID:
21502555

Supplemental Content

Loading ...
Support Center